Skip to main content
Notice2021-20622

SHINE Medical Technologies, LLC; SHINE Medical Isotope Production Facility

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
September 23, 2021

Issuing agencies

Nuclear Regulatory Commission

Abstract

The U.S. Nuclear Regulatory Commission (NRC) is considering issuance of an amendment to Construction Permit No. CPMIF-001, issued to SHINE Medical Technologies, LLC, for the construction of the SHINE Medical Isotope Production Facility. The proposed amendment would allow the receipt and possession of certain radioactive materials necessary for the continued construction of the SHINE Medical Isotope Production Facility. Because this amendment request contains sensitive unclassified non-safeguards information (SUNSI), an order imposes procedures to obtain access to SUNSI for contention preparation.

Indexed from Federal Register on September 23, 2021.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.